Biolase stock forecast.

Biolase Stock (NASDAQ:BIOL), Analyst Ratings, Price Targets, Predictions. Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand ...500. Check out the ideas and forecasts on stocks from top authors of our community. They share predictions and technical outlook of the market to find trending stocks of different countries: India, USA, UK, Japan, etc. Join our financial community to start learning more about the markets. — India.WebBased on 2 Wall Street analysts offering 12 month price targets for Biolase in the last 3 months. The average price target is $4.00 with a high forecast of $4.00 and a low …Biolase, Inc. BIOLNASDAQ BIOLNASDAQ 1.24USD +0.02 +1.64% At close at Nov 24, 13:47 UTC-8 See on Supercharts Overview News Ideas Financials Technicals Forecast …The forecast for beginning of November 32.43. Maximum value 34.48, while minimum 30.58. Averaged Pfizer stock price for month 32.51. Price at the end 32.53, change for November 0.31%. Ford Stock Forecast 2023, 2024, 2025. Gold Price Forecast 2023, 2024-2026. Pfizer stock predictions for December 2024.Web

Oct 26, 2023 · Analyzing the anticipated performance of BIOLASE, the ceiling value that the stock is expected to reach in 2024 stands at a promising $2.56.Indicating a bullish trend, an upside potential of 49.75% signals profitable prospects, with an average monthly return of 3.55%, beckoning investors to consider amplifying their portfolios. BIOLASE is a company that develops and sells laser systems for dental procedures. The stock has a consensus rating of Buy and a price target of $513.50, with a forecasted upside of 30,132.6%. The company reported record revenue and earnings in the second quarter of 2023, and announced a public offering of preferred stock and warrants.

Biolase stock price target cut to $11 from $14 at Ascendiant Capital Mar. 29, 2023 at 6:10 a.m. ET by Tomi Kilgore Biolase started at speculative buy with $2 stock price target at …

Get the latest BIOLASE, Inc. (BIOL) stock news and headlines to help you in your trading and investing decisions.Price Prediction BIOLASE price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions ...Analyzing the anticipated performance of BIOLASE, the ceiling value that the stock is expected to reach in 2025 stands at a promising $2.6.Indicating a bullish trend, an upside potential of 57.68% signals profitable prospects, with an average monthly return of 2.31%, beckoning investors to consider amplifying their portfolios.BIOLASE is a company that develops and sells laser systems for dental procedures. The stock has a consensus rating of Buy and a price target of $513.50, with a forecasted upside of 30,132.6%. The company reported record revenue and earnings in the second quarter of 2023, and announced a public offering of preferred stock and warrants. BIOLASE (BIOL) Stock Forecast & Price Target $1.10 -0.05 (-4.35%) (As of 11/29/2023 ET) Compare Today's Range $1.10 $1.20 50-Day Range $1.10 $1.89 52-Week Range $1.07 $99.50 Volume 88,335 shs Average Volume 156,585 shs Market Capitalization $2.53 million P/E Ratio N/A Dividend Yield N/A Price Target $77.00

The BIOL stock price is -6718.18% off its 52-week high price of $97.50 and 25.17% above the 52-week low of $1.07. If we look at the company’s 10-day average daily trading volume, we find that it stood at 91120.0 shares traded. The 3-month trading volume is 321.12K shares. ... Biolase Inc (BIOL) estimates and forecasts.

2:37p What 2024 S&P 500 forecasts really say about the stock market ... Biolase stock price target cut to $11 from $14 at Ascendiant Capital. Mar. 29, 2023 at 6:10 a.m. ET by Tomi Kilgore.

Get the latest BIOLASE, Inc. (BIOL) stock news and headlines to help you in your trading and investing decisions.Oct 25, 2023 · BIOLASE Stock Forecast 28 Oct. Presumably, on 10/28/2023, the price of shares will be in the range of $1.60 - $1.66. A $0.06 range width can provide 3.89% volatility. The weighted average price of this range is at $1.62, which is $0.01 lower than the previous day's weighted average price. Nov 27, 2023 · The Biolase stock price fell by -6.45% on the last day (Monday, 27th Nov 2023) from $1.24 to $1.16. During the last trading day the stock fluctuated 10.00% from a day low at $1.10 to a day high of $1.21. The price has been going up and down for this period, and there has been a 0.87% gain for the last 2 weeks. The Protalix BioTherapeutics Inc stock price gained 0.719% on the last trading day (Friday, 17th Nov 2023), rising from $1.39 to $1.40. During the last trading day the stock fluctuated 3.28% from a day low at $1.37 to a day high of $1.42. The price has been going up and down for this period, and there has been a -24.32% loss for the last 2 …Biolase Stock Earnings Reports . NASDAQ Stock Exchange > Healthcare > Medical Devices Open Broker Account $1.22 -0.0200 (-1.61%) At Close: Nov 22, 2023 Chart & Forecast Earnings Dividends Insider Trading Signals Historical Prices Predictions News Profile. BIOL Upcoming Earnings (Q4 2023) Earnings Date: Mar 26, 2024

Oct 25, 2023 · BIOLASE Stock Forecast 28 Oct. Presumably, on 10/28/2023, the price of shares will be in the range of $1.60 - $1.66. A $0.06 range width can provide 3.89% volatility. The weighted average price of this range is at $1.62, which is $0.01 lower than the previous day's weighted average price. Company SEC-Filings. Unfortunately, cash burn remains a major issue. In Q2, Biolase recorded negative free cash flow of $6.9 million and ended the quarter with $19.5 million in cash and cash ...WebTrack Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsBIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that based on currently available information, preliminary 2022 fourth quarter revenue is expected to be between ...Dec 1, 2023 · BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants PR Newswire Sep 18, 2023 8:30pm Oct 26, 2023 · Analyzing the anticipated performance of BIOLASE, the ceiling value that the stock is expected to reach in 2024 stands at a promising $2.56.Indicating a bullish trend, an upside potential of 49.75% signals profitable prospects, with an average monthly return of 3.55%, beckoning investors to consider amplifying their portfolios. We feed our Machine Learning (AI based) forecast algorithm data from the most influential global exchanges. There are a number of existing AI-based platforms that try to predict the future of Stock markets. They include data research on historical volume, price movements, latest trends and compare it with the real-time performance of the market.

BIOLASE, Inc. (BIOL) is a global leader in dental lasers, trading on NasdaqCM. The stock price, news, quote and history of BIOLASE, Inc. (BIOL) are available on Yahoo Finance. See the latest performance outlook, earnings date, dividend yield, research reports and more.

Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intraoral scanners. It offers two categories of laser system products: Waterlase (all ...Evelo Biosciences Inc. $0.40. EVLO 1.25% ; Vivos Therapeutics Inc. $19.90. VVOS 18.78% ; Femasys Inc. $0.93. FEMY 2.33% ; Histogen Inc. $0.33. HSTO 2.19% ; BIOLASE ...The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.Get the latest news and real-time alerts from BIOLASE, Inc. (BIOL) stock at Seeking Alpha. ... Biolase gains after forecasting strong near-term outlook SA News Thu, Aug. 12, 2021.How much is Biolase stock worth today? ( NASDAQ: BIOL) Biolase currently has 2,296,777 outstanding shares. With Biolase stock trading at $1.25 per share, the total …BIOLASE, Inc. Provides Revenue Forecast for the Third Quarter Ending September 30, 2022 and Full Year of 2022 ... Listing Qualifications Staff of Nasdaq Determines to Delist BIOLASE's Common Stock from the Nasdaq Capital Market and to Suspend Trading of the Common Stock at the Opening of Business on June 20 2023.Discover historical prices for BIOL stock on Yahoo Finance. View daily, weekly or monthly format back to when BIOLASE, Inc. stock was issued.The BIOLASE stock prediction results are shown below and presented as a graph, table and text information. BIOLASE stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for BIOLASE analysts is $ 21.38. Today 200 Day Moving Average is the resistance level (15.93 $).About the Alphabet, Inc. stock forecast. As of 2023 December 02, Saturday current price of GOOGL stock is 132.450$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Alphabet Inc Class A stock price as been showing a rising tendency so we believe that similar market segments …

It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...

21 sept 2023 ... Shares of Biolase saw signs of life in the stock market today. The ... Instead of waiting for its share price to climb, it has conducted a ...

About the Alphabet, Inc. stock forecast. As of 2023 December 02, Saturday current price of GOOGL stock is 132.450$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Alphabet Inc Class A stock price as been showing a rising tendency so we believe that similar market segments …The Biolase Inc (BIOL) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $21.75, representing a +1,639% increase from the current price of $1.2506. The highest analyst price target is $42.41, and the lowest is $1.0934. Biolase, Inc. BIOLNASDAQ BIOLNASDAQ 1.24USD +0.02 +1.64% At close at Nov 24, 13:47 UTC-8 See on Supercharts Overview News Ideas Financials Technicals Forecast …Sell candidate since Nov 06, 2023 Loss -8.41% PDF. The SoFi stock price fell by -0.580% on the last day (Friday, 24th Nov 2023) from $6.90 to $6.86. During the last trading day the stock fluctuated 2.35% from a day low at $6.79 to a day high of $6.95. The price has risen in 6 of the last 10 days and is up by 0.15% over the past 2 weeks.The medical device company, Biolase ( NASDAQ: BIOL) has lost ~17% in the pre-market Friday as its shares begin trading on a split adjusted basis after the company’s shareholders approved a ...BIOLASE Stock Earnings. The value each BIOL share was expected to gain vs. the value that each BIOL share actually gained. BIOLASE ( BIOL) reported Q2 2023 earnings per share (EPS) of -$8.93, missing estimates of -$5.33 by 67.48%. In the same quarter last year, BIOLASE 's earnings per share (EPS) was -$90.62. BIOLASE is expected to release next ...Oct 26, 2021 · For BIOLASE stock forecast for 2031, 12 predictions are offered for each month of 2031 with average BIOLASE stock forecast of $1.91, a high forecast of $3.64, and a low forecast of $0.72. The average BIOLASE stock forecast 2031 represents a 66.26% increase from the last price of $1.14999997615814. For BIOLASE stock forecast for 2033 (10 year ... TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comWebThe Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.BIOLASE Inc Follow Share $1.22 After Hours: $1.25 (2.79%) +0.034 Closed: Nov 24, 3:59:26 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to NovaBay Pharmaceuticals Inc $0.32 NBY3.38% T2...

US0909117022. BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to ...Dec 1, 2023 · Full Company Report for BIOL. View Biolase, Inc BIOL investment & stock information. Get the latest Biolase, Inc BIOL detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Real time Biolase (BIOL) stock price quote, stock graph, news & analysis. Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Instagram:https://instagram. scott trade logintop finance stocksinstacart stock quoteumbrella insurance carriers Biolase Simple Moving Average . Analysis of Biolase Simple Moving Average, A two period moving average forecast for Biolase is based on an daily price series in which the stock price on a given d... marc chaikin stock to buyvgt dividend When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week. hedge fund companies BIOLASE stock has a strong buy rating from 3 analysts, who predict an increase of 6,566.47% to $113.33 in the next 12 months. The average price target is $100, with a range of $40 to $200. The stock has a low revenue growth rate and a high EPS loss in the past year.BIOLASE, Inc. Provides Revenue Forecast for the Third Quarter Ending September 30, 2022 and Full Year of 2022 Aug 12 BIOLASE, Inc. to Report Q2, 2022 Results on Aug 11, 2022